interferon beta/albumin fusion protein (CoGenesys)

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug Nameinterferon beta/albumin fusion protein (CoGenesys)
Drug Alias NameAlbu-Interferon betab-Interferonalbumin + interferon beta (Teva Pharmaceutical)
ClassificationBiologics > Protein drugs > Recombinant protein > Fusion protein
Mechanisms of ActionInterferon alpha/beta receptor agonists
TargetsInterferon alpha/beta receptor
Therapy Area/IndicationsMultiple Sclerosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesCogenesys
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesCogenesysTeva Pharmaceutical Industries Ltd
Active IndicationsN/A
Inactive IndicationsMultiple Sclerosis

Other Information

ATC CodeN/A
Related LinksN/A